Current Status and Clinical Application Analysis of PGT-A Genetic Screening Technology in Georgia
Georgia PGT-A technology is primarily based on the NGS sequencing platform, used to screen for chromosomal aneuploidy in embryos, suitable for advanced maternal age, recurrent miscarriage, and repeated implantation failure populations. This article provides objective, professional knowledge base content from the perspectives of technical workflow, suitable populations, differences between countries, cost structure, and common misconceptions, helping users build accurate understanding.
Read More